Ideaya Biosciences

Filed a patent for "method of treating cancer using parg modulators" on Fri, January 6, 2023

Filed a patent for "heteroaryl-substituted pyrazolo/imidazo pyridine compounds" on Tue, February 14, 2023

Filed a patent for "heteroaryl-substituted benzimidazole compounds" on Tue, February 14, 2023

Filed a patent for "amide and ester-substituted imidazopyridine compounds" on Tue, February 14, 2023

Filed a patent for "heteroaryl-substituted imidazopyridine compounds" on Tue, February 14, 2023

Filed a patent for "cancer treatments using mta-cooperative prmt5 inhibitors and mat2a inhibitors" on Mon, February 27, 2023

Filed a patent for "combination therapy comprising a parg inhibitor and a topoisomerase inhibitor" on Wed, April 5, 2023

Filed a patent for "cancer treatments using mta-cooperative prmt5 inhibitors and mat2a inhibitors" on Tue, April 11, 2023

Filed a patent for "combination therapy comprising a mat2a inhibitor and a topoisomerase inhibitor, a splicing inhibitor sulfonamide, or a kif18 inhibitor" on Thu, April 13, 2023

Filed a patent for "methods of treating hepatic-only metastatic uveal melanoma" on Fri, April 21, 2023

Filed a patent for "combination therapy comprising a parg inhibitor and a topoisomerase inhibitor" on Wed, September 20, 2023

Filed a patent for "amide and ester-substituted imidazopyridine compounds" on Wed, September 27, 2023

Filed a patent for "heteroaryl-substituted pyrazolo/imidazo pyridine compounds" on Wed, September 27, 2023

Filed a patent for "heteroaryl-substituted benzimidazole compounds" on Wed, September 27, 2023

Filed a patent for "heteroaryl-substituted imidazopyridine compounds" on Wed, September 27, 2023

Filed a patent for "combination therapy comprising a mat2a inhibitor and a topoisomerase inhibitor, a splicing inhibitor sulfonamide, or a kif18 inhibitor" on Tue, November 14, 2023

Filed a patent for "combination therapy comprising a parg inhibitor and a topoisomerase inhibitor" on Tue, November 14, 2023

Filed a patent for "method of treating cancer using parg modulators" on Fri, December 1, 2023

Filed a patent for "combination therapy comprising a mat2a inhibitor and a taxane" on Wed, May 8, 2024

Filed a patent for "thiadiazolyl derivatives as dnapolymerase theta inhibitors and usesthereof" on Thu, October 3, 2024

Filed a patent for "methods of treating uveal melanoma" on Fri, September 9, 2022

Filed a patent for "methods of treating uveal melanoma with a pkc inhibitor" on Fri, September 9, 2022

Filed a patent for "quinolinone derivatives as methionine adenosyltransferase 2a inhibitors" on Thu, July 20, 2023

Filed a patent for "4-arylquinazoline derivatives as methionine adenosyltransferase 2a inhibitors" on Thu, August 17, 2023

Filed a patent for "2-aminoquinazolinone derivatives as methionine adenosyltransferase 2a inhibitors" on Thu, August 17, 2023